Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuedong Li

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
ACS Applied Materials & Interfaces|April 11, 2023
Hybrid Ligand Polymerization for Weakly Confined Lead Halide Perovskite Quantum DotsXianghua Wang, Shaoqi Zhuo, Jing Fu, et al.
Oncology Reports|May 13, 2017
Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinomaXuedong Li, Qing Chen, Dan Yin, et al.
Cell Biology and Toxicology|March 20, 2025
CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancerHaitao Xu, Shaoyue Zheng, Qiuqi Zhang, et al.
The New Phytologist|May 19, 2021
Functional specificity, diversity, and redundancy of Arabidopsis JAZ family repressors in jasmonate and COI1-regulated growth, development, and defenseBei Liu, Kyungyong Seong, Shihai Pang, et al.
International Journal of Nanomedicine|September 24, 2014
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functionsWenji Zhang, Xuedong Li, Tiantian Ye, et al.
Nucleic Acids Research|November 6, 2023
INTEDE 2.0: the metabolic roadmap of drugsYang Zhang, Xingang Liu, Fengcheng Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 27, 2021
Endothelial dysfunction in pathological processes of chronic liver disease during agingYing Wan, Xuedong Li, Elise Slevin, et al.
Journal of Pharmaceutical Analysis|October 6, 2025
Discovery of selective HDAC6 inhibitors driven by artificial intelligence and molecular dynamics simulation approachesXingang Liu, Hao Yang, Xinyu Liu, et al.
Frontiers in Immunology|July 25, 2025
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysisBo Han, Weiyang Liu, Wanhui Wang, et al.
Frontiers in Pharmacology|July 1, 2021
Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling PathwaysXue Yang, Jiamin Liang, Ziyi Wang, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
ACS Applied Materials & Interfaces|April 11, 2023
Hybrid Ligand Polymerization for Weakly Confined Lead Halide Perovskite Quantum DotsXianghua Wang, Shaoqi Zhuo, Jing Fu, et al.
Oncology Reports|May 13, 2017
Novel role of semaphorin 3A in the growth and progression of hepatocellular carcinomaXuedong Li, Qing Chen, Dan Yin, et al.
Cell Biology and Toxicology|March 20, 2025
CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancerHaitao Xu, Shaoyue Zheng, Qiuqi Zhang, et al.
The New Phytologist|May 19, 2021
Functional specificity, diversity, and redundancy of Arabidopsis JAZ family repressors in jasmonate and COI1-regulated growth, development, and defenseBei Liu, Kyungyong Seong, Shihai Pang, et al.
International Journal of Nanomedicine|September 24, 2014
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functionsWenji Zhang, Xuedong Li, Tiantian Ye, et al.
Nucleic Acids Research|November 6, 2023
INTEDE 2.0: the metabolic roadmap of drugsYang Zhang, Xingang Liu, Fengcheng Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 27, 2021
Endothelial dysfunction in pathological processes of chronic liver disease during agingYing Wan, Xuedong Li, Elise Slevin, et al.
Journal of Pharmaceutical Analysis|October 6, 2025
Discovery of selective HDAC6 inhibitors driven by artificial intelligence and molecular dynamics simulation approachesXingang Liu, Hao Yang, Xinyu Liu, et al.
Frontiers in Immunology|July 25, 2025
CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysisBo Han, Weiyang Liu, Wanhui Wang, et al.
Frontiers in Pharmacology|July 1, 2021
Sesamolin Protects Mice From Ovariectomized Bone Loss by Inhibiting Osteoclastogenesis and RANKL-Mediated NF-κB and MAPK Signaling PathwaysXue Yang, Jiamin Liang, Ziyi Wang, et al.
Pageof 12